• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增殖性糖尿病视网膜病变患者25G玻璃体切割术后复发性玻璃体出血的危险因素

Risk Factors for Recurrent Vitreous Hemorrhage After 25-Gauge Pars Plana Vitrectomy in Patients With Proliferative Diabetic Retinopathy.

作者信息

Bitra Jyotsna, Sureshkumar Haarisudhan, Eathara Abhijith V, Alahmadi Reem, Heiferman Michael J

机构信息

Department of Ophthalmology and Visual Sciences, University of Illinois College of Medicine, Chicago, IL, USA.

Vitreoretinal Division, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.

出版信息

J Vitreoretin Dis. 2025 Jul 8:24741264251351545. doi: 10.1177/24741264251351545.

DOI:10.1177/24741264251351545
PMID:40656516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12240989/
Abstract

To report the incidence of and risk factors associated with recurrent vitreous hemorrhage (VH) in eyes that had 25-gauge pars plana vitrectomy (PPV) for proliferative diabetic retinopathy (PDR). This study included 220 eyes of 185 patients who were 21 years old or older and who had PPV for PDR and a minimum postoperative follow-up of 3 months. For patients who had bilateral PPV, data were gathered from both eyes. If surgery was performed in only 1 eye, data were collected from that eye alone. The incidence of recurrent VH was 34.5% (76 eyes). The VH was categorized as early in 46 eyes (60.5%), delayed in 8 eyes (10.5%), or late in 22 eyes (28.9%). Sixty-eight eyes (89.5%) had mild/moderate recurrent VH and 8 (10.5%) had severe recurrent VH. The mean preoperative fasting blood glucose level was 147.7 mg/dL in eyes without recurrent VH and 176.7 mg/dL in eyes with recurrent VH ( = .020). Younger age ( = .027) and higher diastolic blood pressure at the time of surgery ( = .005) also significantly affected recurrent VH. Younger age, preoperative fasting blood glucose levels, and diastolic blood pressure were significantly associated with recurrent VH after PPV in patients with PDR.

摘要

报告接受25G玻璃体切割术(PPV)治疗增生性糖尿病视网膜病变(PDR)的患眼中复发性玻璃体出血(VH)的发生率及相关危险因素。本研究纳入了185例年龄在21岁及以上、因PDR接受PPV且术后至少随访3个月的患者的220只眼。对于接受双侧PPV的患者,双眼均收集数据。若仅一只眼进行了手术,则仅收集该眼的数据。复发性VH的发生率为34.5%(76只眼)。VH被分类为早期46只眼(60.5%)、延迟性8只眼(10.5%)或晚期22只眼(28.9%)。68只眼(89.5%)发生轻度/中度复发性VH,8只眼(10.5%)发生重度复发性VH。无复发性VH的患眼术前空腹血糖平均水平为147. mg/dL,有复发性VH的患眼为176.7 mg/dL(P = 0.020)。年龄较轻(P = 0.027)以及手术时较高的舒张压(P = 0.005)也对复发性VH有显著影响。年龄较轻、术前空腹血糖水平及舒张压与PDR患者PPV术后复发性VH显著相关。

相似文献

1
Risk Factors for Recurrent Vitreous Hemorrhage After 25-Gauge Pars Plana Vitrectomy in Patients With Proliferative Diabetic Retinopathy.增殖性糖尿病视网膜病变患者25G玻璃体切割术后复发性玻璃体出血的危险因素
J Vitreoretin Dis. 2025 Jul 8:24741264251351545. doi: 10.1177/24741264251351545.
2
Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.抗血管内皮生长因子预防增殖性糖尿病视网膜病变玻璃体切除术后玻璃体腔出血
Cochrane Database Syst Rev. 2015 Aug 7;2015(8):CD008214. doi: 10.1002/14651858.CD008214.pub3.
3
Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.抗血管内皮生长因子治疗增生型糖尿病视网膜病变。
Cochrane Database Syst Rev. 2023 Mar 20;3(3):CD008721. doi: 10.1002/14651858.CD008721.pub3.
4
A Pilot Randomized Controlled Trial Evaluating Hemostasis With Fibrin Glue During Surgery for Proliferative Diabetic Retinopathy.
Am J Ophthalmol. 2025 Apr;272:117-125. doi: 10.1016/j.ajo.2025.01.016. Epub 2025 Jan 28.
5
Ocriplasmin for symptomatic vitreomacular adhesion.用于有症状性玻璃体黄斑粘连的奥克纤溶酶
Cochrane Database Syst Rev. 2017 Oct 17;10(10):CD011874. doi: 10.1002/14651858.CD011874.pub2.
6
Correlation Between Postoperative Vitreous Hemorrhage and Preoperative Evaluation of Optical Coherence Tomography Angiography in Proliferative Diabetic Retinopathy Surgery.增殖性糖尿病视网膜病变手术中术后玻璃体出血与术前光学相干断层扫描血管造影评估的相关性
J Ophthalmol. 2025 Jul 5;2025:7839246. doi: 10.1155/joph/7839246. eCollection 2025.
7
Surgical interventions for bilateral congenital cataract in children aged two years and under.儿童两岁及以下双侧先天性白内障的手术干预。
Cochrane Database Syst Rev. 2022 Sep 15;9(9):CD003171. doi: 10.1002/14651858.CD003171.pub3.
8
Laser therapy for retinopathy in sickle cell disease.镰状细胞病视网膜病变的激光治疗
Cochrane Database Syst Rev. 2015 Oct 9;2015(10):CD010790. doi: 10.1002/14651858.CD010790.pub2.
9
Risk of Progression of Nonproliferative to Proliferative Diabetic Retinopathy after Cataract Surgery.白内障手术后非增殖性糖尿病视网膜病变进展为增殖性糖尿病视网膜病变的风险。
Ophthalmology. 2025 Jul;132(7):817-822. doi: 10.1016/j.ophtha.2025.02.006. Epub 2025 Feb 15.
10
Laser therapy for retinopathy in sickle cell disease.激光疗法治疗镰状细胞病视网膜病变。
Cochrane Database Syst Rev. 2022 Dec 12;12(12):CD010790. doi: 10.1002/14651858.CD010790.pub3.

本文引用的文献

1
Antiplatelets and Anticoagulants in Vitreoretinal Surgery: A Systematic Review.玻璃体视网膜手术中的抗血小板药物和抗凝药物:一项系统评价
Life (Basel). 2023 Jun 9;13(6):1362. doi: 10.3390/life13061362.
2
Persistence of Poverty and its Impact on Surgical Care and Postoperative Outcomes.贫困的持续存在及其对手术护理和术后结果的影响。
Ann Surg. 2023 Sep 1;278(3):347-356. doi: 10.1097/SLA.0000000000005953. Epub 2023 Jun 15.
3
Risk Factors for Recurrent Vitreous Hemorrhage in Type 2 Diabetes Mellitus Patients after Posterior Vitrectomy.2型糖尿病患者玻璃体切除术后复发性玻璃体出血的危险因素
J Clin Med. 2023 Apr 20;12(8):2989. doi: 10.3390/jcm12082989.
4
Outcomes of Pars Plana Vitrectomy with Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy Without Retinal Detachment: A Seven-Year Retrospective Study.不伴有视网膜脱离的增生性糖尿病视网膜病变行玻璃体切割联合全视网膜光凝术的疗效:一项七年回顾性研究
Clin Ophthalmol. 2023 Feb 1;17:471-478. doi: 10.2147/OPTH.S400474. eCollection 2023.
5
Impact of low health literacy on patients' health outcomes: a multicenter cohort study.低健康素养对患者健康结局的影响:一项多中心队列研究。
BMC Health Serv Res. 2022 Sep 12;22(1):1148. doi: 10.1186/s12913-022-08527-9.
6
Household Income as a Predictor for Surgical Outcomes and Opioid Use After Spine Surgery in the United States.美国脊柱手术后家庭收入作为手术结果和阿片类药物使用的预测指标
Global Spine J. 2023 Oct;13(8):2124-2134. doi: 10.1177/21925682211070823. Epub 2022 Jan 10.
7
Racial/Ethnic Disparities and Barriers to Diabetic Retinopathy Screening in Youths.青少年糖尿病视网膜病变筛查中的种族/民族差异和障碍。
JAMA Ophthalmol. 2021 Jul 1;139(7):791-795. doi: 10.1001/jamaophthalmol.2021.1551.
8
Perioperative anti-vascular endothelial growth factor agents treatment in patients undergoing vitrectomy for complicated proliferative diabetic retinopathy: a network meta-analysis.接受玻璃体切除术治疗复杂性增生型糖尿病视网膜病变患者的围手术期抗血管内皮生长因子药物治疗:一项网状荟萃分析。
Sci Rep. 2020 Nov 3;10(1):18880. doi: 10.1038/s41598-020-75896-8.
9
Multiple factors in the prediction of risk of recurrent vitreous haemorrhage after sutureless vitrectomy for non-clearing vitreous haemorrhage in patients with diabetic retinopathy.糖尿病视网膜病变患者非清除性玻璃体积血行无缝线玻璃体切除术后复发性玻璃体积血风险预测的多因素分析
BMC Ophthalmol. 2020 Jul 16;20(1):292. doi: 10.1186/s12886-020-01532-8.
10
Predictors of Lost to Follow-Up in Patients Being Treated for Proliferative Diabetic Retinopathy.增殖型糖尿病视网膜病变患者失访的预测因素。
Am J Ophthalmol. 2020 Aug;216:18-27. doi: 10.1016/j.ajo.2020.03.023. Epub 2020 Mar 31.